Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Ocular Immunology and Inflammation|August 11, 2018
Ocular Nocardiosis: A Case ReportReinhard Angermann, Martin Stattin, Claus ZehetnerKlinische Monatsblatter Fur Augenheilkunde|April 21, 2022
The Impact of the COVID-19 Pandemic on the Quality of Care of Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal AfliberceptReinhard Angermann, Alexander Franchi, Katharina Frede, et al.Ophthalmology and Therapy|January 20, 2022
Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up InvestigationReinhard Angermann, Alexander Franchi, Victoria Stöckl, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 4, 2018
Triamcinolone in small-gauge vitrectomy for epiretinal membrane peelingReinhard Angermann, Claus Zehetner, Patrick Sidoroff, et al.Journal of Ophthalmology|March 10, 2020
Effect of Timing on Visual Outcomes in Fovea-Involving Retinal Detachments Verified by SD-OCTReinhard Angermann, Nikolaos E Bechrakis, Teresa Rauchegger, et al.Klinische Monatsblatter Fur Augenheilkunde|November 27, 2019
[Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naïve Patients with nAMD under Intravitreal Aflibercept Therapy]Teresa Rauchegger, Reinhard Angermann, Anja Meusburger, et al.Case Reports in Ophthalmology|October 11, 2016
Decreased Vision as Initial Presenting Symptom of Acute Lymphoblastic Leukemia: A Case ReportChristoph Palme, Nikolaos E Bechrakis, Martin Stattin, et al.Journal of Ophthalmology|December 27, 2021
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular DegenerationAnna Lena Huber, Reinhard Angermann, Yvonne Nowosielski, et al.BMC Ophthalmology|September 19, 2022
Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective studyReinhard Angermann, Alexander Franchi, Katharina Frede, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 10, 2019
Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverageReinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, et al.Pageof 7